Current status of MEK inhibitors in the treatment of plexiform neurofibromas
Crossref DOI link: https://doi.org/10.1007/s00381-020-04731-2
Published Online: 2020-06-30
Published Print: 2020-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gross, Andrea M.
Dombi, Eva
Widemann, Brigitte C. https://orcid.org/0000-0002-9198-7175
Text and Data Mining valid from 2020-06-30
Version of Record valid from 2020-06-30
Article History
Received: 2 June 2020
Accepted: 5 June 2020
First Online: 30 June 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.